Optical Coherence Tomography in Acute Vessel Evaluation | MicrobiomeTrials← Back to trialsNCT07422688
Optical Coherence Tomography in Acute Vessel Evaluation
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2025-11-23Est. Completion: 2030-09-01
Enrollment target: 3,000 participants Locations- Leuven University Hospital, Leuven, Belgium
- Aalborg University Hospital, Aalborg, Denmark
- Aarhus University Hospital Skejby, Aarhus N, Denmark
- Rigshospitalet, København Ø, Denmark
- Odense University Hospital, Odense, Denmark
- Zealand University Hospital, Roskilde Sygehus, Roskilde, Denmark
- North-Estonia Medical Centre, Tallinn, Estonia
- North Karelia Central Hospital, Joensuu, Finland
- Vivantes Klinikum im Friedrichshain, Berlin, Germany
- Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
- Turin Nord Emergency Hospital, Turin, Italy
- Latvia Centre of Cardiology, Riga, Latvia
- Radboud University Medicine Center, Nijmegen, Netherlands
- Hospital of Southern Norway, Arendal, Arendal, Norway
- Akerhus University Hospital - AHUS, Lørenskog, Norway
- Sahlgrenska University Hospital, Gothenburg, Sweden
- Karolinska Universitetssjukhuset, Stockholm, Sweden
- University Hospital of Zürich, Zurich, Switzerland
Other microbiome trials you might be interested in
Myocardial Infarction (MI)
There is a knowledge gap in the literature around using watts to measure exercise intensity in walking and running, this…
Multiple LocationsEst. completion Jan 31, 2027
Coronary Artery Disease (CAD)
This randomized controlled study aims to evaluate the effects of a combined mind-body intervention consisting of progres…
Ankara, Turkey (Türkiye)Est. completion Aug 2026
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Royal Bournemouth Hospital, Bournemouth, United KingdomAcute myocardial infarction is one of the leading causes of death in elderly patients, and the importance of lipid-lower…
Multiple LocationsEst. completion Jun 1, 2028